SIGNAL Trial [ 2013 - ]

Research Grant

Researchers: Prof Vlado Perkovic (Principal investigator) ,  A/Pr Meg Jardine ,  Prof Adeera Levin ,  Prof Alan Cass ,  Prof David Johnson
View all 8 related researchers

Brief description IgA nephropathy is one of the most common causes of kidney failure in Australia and around the world, but there are currently no specific treatments proven to prevent kidney failure. The SIGNAL trial, jointly led by Australian and Chinese researchers, will bring together leading experts from around the world to reliably ascertain the effects of steroid therapy in this condition, and could potentially prevent many people from developing kidney failure in the future.

Funding Amount $2,681,619.00

Funding Scheme Project Grants

Notes Standard Project Grant